Liabilities / Assets
6th percentile
Higher debt load relative to assets than 6% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
6th percentile
Higher debt load relative to assets than 6% of similar nonprofits.
Liabilities / Revenue
12th percentile
Higher debt load relative to revenue than 12% of similar nonprofits.
Net Margin
90th percentile
Higher net margin than 90% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
58th percentile
Faster asset growth than 58% of similar nonprofits.
Revenue Growth
80th percentile
Faster revenue growth than 80% of similar nonprofits.
Assets
Up$125,096,605
Up $8,463,943 (+7.3%) from 2013
Net Assets
Up$124,309,869
Up $8,423,329 (+7.3%) from 2013
Liabilities
Up$786,736
Up $40,614 (+5.4%) from 2013
Revenue
Up$8,640,133
Up $1,402,798 (+19%) from 2013
Expenses
Down$4,686,966
Down $1,926,365 (-29%) from 2013
Net Income
Up$3,953,167
Up $3,329,163 (+534%) from 2013
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
As a supporting organization to the Clayton Foundation for Research (Clayton), the organizations primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Claytons other supporting entities.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2014 • Form 990Summary only. Only limited summary data is available for this year.